BACKGROUND
The nationwide impact in Japan of contemporary improvement in the clinical management of durable left ventricular assist device (LVAD), together with the introduction of the HeartMate 3 (Abbott, Pleasanton, CA, USA), on clinical outcomes remains uncertain.
METHODS AND RESULTS
Using the Japanese Registry fo...
Teruhiko Imamura, K. Kinugawa, Takashi Nishimura et al.· Circulation Journal· 0 citations
BACKGROUND
As Japan faces a heart failure (HF) pandemic, geriatric health service facilities (GHSFs) are vital for transitional HF care from hospital to home. This study investigated HF care practices, challenges, and support needs in Japanese GHSFs.
METHODS AND RESULTS
We conducted a cross-sectional web-based survey...
Y. Kinugasa, Miyuki Tsuchihashi-Makaya, Akiko Okada et al.· Circulation Journal· 0 citations
BACKGROUND
Nafamostat mesilate (NM), a synthetic serine protease inhibitor, has been used as an anticoagulant in patients undergoing extracorporeal circulatory support who have bleeding or heparin-related adverse effects. The safety and efficacy of NM-based anticoagulation in patients receiving Impella support who deve...
M. Nakamura, Teruhiko Imamura, M. Nakagaito et al.· Artificial Organs· 0 citations
This nationwide real-world study provides the first validation of a nationally mandated DT eligibility algorithm and may support risk-based clinical decision-making in Japanese DT practice.
Teruhiko Imamura, K. Kinugawa, Takashi Nishimura et al.· JACC: Asia· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
